Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 653
interventional 539
Observational 104
Registry 10

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 215
Biological 37
Procedure 33
Other 30
Device 22
Drug|Procedure 21
Biological|Drug 20
Drug|placebo 20
Drug|Other 13
Radiation 12
Drug|Radiation 10
Behavioral 8
Drug|Procedure|Radiation 8
Biological|Drug|Procedure 7
Biological|Other 7
Diagnostic Test 7
Biological|Drug|Other 5
Device|Drug 5
Device|Procedure 5
Dietary Supplement 5
Drug|placebo|Procedure 4
Biological|Drug|Radiation 3
Combination Product 3
Drug|Other|Radiation 3
Genetic 3
Behavioral|Other 2
Biological|Drug|placebo 2
Biological|Other|Procedure 2
Device|Other 2
Dietary Supplement|placebo 2
Behavioral|Drug 1
Behavioral|Drug|Genetic|Other|Procedure 1
Behavioral|Drug|Other 1
Behavioral|Other|Procedure 1
Behavioral|Procedure 1
Biological|Drug|Procedure|Radiation 1
Biological|Procedure 1
Biological|Radiation 1
Combination Product|Drug|Procedure 1
Device|Drug|Procedure 1
Device|Other|Procedure 1
Dietary Supplement|Drug 1
Dietary Supplement|Drug|Other|placebo 1
Dietary Supplement|Drug|Radiation 1
Dietary Supplement|Other|placebo 1
Dietary Supplement|Other|placebo|Procedure 1
Dietary Supplement|Other|Procedure|Radiation 1
Drug|Other|placebo 1
Drug|Other|placebo|Procedure 1
Drug|placebo|Radiation 1
Genetic|Radiation 1
Other|Radiation 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 253
NA 19
Denmark 18
China 16
Italy 16
United Kingdom 16
France 15
United States|Canada 15
Canada 12
Egypt 12
Korea, Republic of 12
Spain 7
Netherlands 6
Switzerland 6
Germany 5
Israel 5
Belgium 4
Finland 4
Hong Kong 3
India 3
Sweden 3
Australia 2
Australia|New Zealand 2
Austria 2
Belgium|France 2
Egypt|Germany 2
Greece 2
Japan 2
Poland 2
United States|Canada|France|Germany|Italy|Netherlands|Spain|United Kingdom 2
United States|Israel 2
Australia|Austria|Belgium|Canada|France|Germany|Japan|Netherlands|Poland|Russian Federation|Slovakia|Spain|United Kingdom 1
Australia|Austria|Denmark|Germany|Netherlands|United Kingdom 1
Australia|New Zealand|United Kingdom 1
Austria|Belgium|Denmark|Germany|Hungary|Israel|Italy|Netherlands|Poland|Spain|United Kingdom 1
Austria|Belgium|France|Greece|Israel|Italy|Netherlands|Portugal|Romania|Turkey|United Kingdom 1
Belarus 1
Belgium|France|Israel|Italy|Netherlands|Spain|Switzerland 1
Belgium|Italy|Netherlands|Portugal|Turkey|United Kingdom 1
Brazil|Canada|Finland|Netherlands|New Zealand|Norway|South Africa|United Kingdom 1
Canada|Spain 1
Canada|United States|Germany|Spain|United Kingdom 1
China|Korea, Republic of 1
Czechia 1
Denmark|Sweden 1
France|Germany|United States|Canada|Italy|Poland|Spain 1
France|Netherlands|Spain|United Kingdom 1
France|United States|Australia|Belgium|Brazil|Canada|Chile|Czechia|Germany|Israel|Italy|Japan|Korea, Republic of|Netherlands|Philippines|Poland|Russian Federation|Spain|Taiwan|Turkey|United Kingdom|Vietnam 1
Germany|Israel|Netherlands|Spain 1
Germany|Switzerland 1
Germany|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Colombia|Denmark|Finland|France|Greece|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Norway|Portugal|Romania|Russian Federation|Singapore|Spain|Taiwan|United Kingdom 1
Ghana 1
Israel|Italy|Spain|Switzerland 1
Nepal 1
Philippines|United States|Australia|Belgium|Canada|Denmark|France|Greece|Indonesia|Italy|Korea, Republic of|Poland|Russian Federation|Spain|Thailand|United Kingdom 1
Russian Federation 1
Saudi Arabia 1
Singapore 1
Spain|United States 1
Spain|United States|France|Germany|Italy|United Kingdom 1
Turkey 1
United Kingdom|United States|Belgium|Denmark|Sweden 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czechia|France|Germany|Greece|Netherlands|New Zealand|Poland|Russian Federation|Spain|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Denmark|Finland|France|Germany|Greece|Israel|Italy|Mexico|Netherlands|Poland|Portugal|Puerto Rico|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|France|Germany|Ireland|Netherlands|Singapore|Spain|Sweden|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|France|India|Israel|Italy|Mexico|Netherlands|Poland|Russian Federation|South Africa|Spain|Sweden|Turkey 1
United States|Argentina|Australia|Brazil|Canada|Chile|China|France|Hong Kong|Italy|Mexico|Netherlands|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Argentina|Belgium|Croatia|France|Spain 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|Finland|France|Germany|Greece|Hungary|Italy|Japan|Korea, Republic of|Netherlands|Norway|Poland|Portugal|Romania|Russian Federation|Serbia|Slovenia|Spain|Sweden|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Finland|Germany|Greece|Italy|Japan|Korea, Republic of|Malaysia|Netherlands|Norway|Peru|Poland|Portugal|Spain|Switzerland|Turkey|United Kingdom 1
United States|Australia|Austria|Canada|France|Greece|Indonesia|Italy|Korea, Republic of|Philippines|Singapore|Spain|Sweden|Switzerland|Thailand 1
United States|Australia|Austria|France|Germany|Israel|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Taiwan|Thailand|Turkey 1
United States|Australia|Belgium|Brazil|China|Czechia|France|Germany|Italy|Japan|Korea, Republic of|Poland|Spain|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Germany|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Sweden|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Germany|Hungary|Ireland|Israel|Italy|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Sweden|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Canada|Finland|France|Greece|Italy|Japan|Korea, Republic of|Netherlands|Russian Federation|Sweden|Turkey 1
United States|Australia|United Kingdom 1
United States|Austria|Canada|Germany|Netherlands 1
United States|Belgium|Denmark|Hungary|United Kingdom 1
United States|Belgium|Korea, Republic of|Netherlands|Poland 1
United States|Bulgaria|Italy|Poland|Romania 1
United States|Canada|France|Spain|United Kingdom 1
United States|Canada|Korea, Republic of|Russian Federation|Spain|Taiwan|Vietnam 1
United States|Canada|Poland 1
United States|Canada|Puerto Rico 1
United States|China|Korea, Republic of 1
United States|Czechia|Denmark|Estonia|Israel|Italy|Korea, Republic of|Taiwan|Turkey|Ukraine 1
United States|Denmark|United Kingdom 1
United States|France|Australia|Austria|Belgium|Canada|Denmark|Germany|Hungary|Israel|Italy|Netherlands|Poland|Slovakia|Spain|United Kingdom 1
United States|France|Germany|Italy|Japan|Korea, Republic of|Netherlands|Spain 1
United States|France|Netherlands|Spain 1
United States|France|Spain 1
United States|Germany|Netherlands|Spain|Ukraine|United Kingdom 1
United States|Italy 1
United States|Korea, Republic of|Poland 1
United States|Korea, Republic of|Taiwan 1
United States|Netherlands 1
United States|Puerto Rico 1
United States|Puerto Rico|South Africa 1
United States|South Africa 1

Sites per Study

Site_count Study_Count
1 269
2 50
3 18
4 13
5 16
6 10
7 12
8 7
9 7
10 10
11 9
12 6
13 6
14 6
15 3
16 8
17 3
18 2
19 1
20 2
21 3
22 5
25 2
26 2
27 3
28 1
29 3
30 3
31 1
32 1
34 2
35 2
36 1
38 1
40 1
42 1
43 1
48 1
49 1
50 2
55 1
61 1
62 1
64 2
70 2
74 3
75 1
76 1
77 3
80 1
92 1
95 1
98 1
108 1
112 1
120 1
121 1
122 1
128 1
130 1
135 1
137 1
139 1
142 1
160 1
163 1
172 1
184 1
185 1
197 1
217 1
229 1
234 1
272 1
285 1
508 1
566 1
1329 1

Phase

Phase Study_Count
Phase 2 192
N/A 120
Phase 1 85
Phase 3 63
Phase 1/Phase 2 48
Early Phase 1 12
Phase 2/Phase 3 10
Phase 4 9

Number of Arms

Number_of_Arms Count_of_Studies
1 230
2 186
3 35
4 8
5 5
6 2
8 2
10 1
11 1
37 1
NA 68

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 2.00 4.00 6.00000 2.00000 2.0000 25.00 21.0000 54.0000
1st Qu. 13.75 32.75 18.00000 21.00000 32.7500 131.75 216.5000 108.0000
Median 22.50 76.00 30.00000 49.00000 51.0000 195.00 399.0000 200.0000
Mean 30.25 177.00 43.60494 82.53191 117.0707 205.30 479.1333 262.6667
3rd Qu. 30.00 177.75 42.00000 77.50000 90.0000 326.75 619.5000 400.0000
Max. 150.00 1928.00 344.00000 596.00000 6452.0000 354.00 1869.0000 642.0000

Trial Group Type

group_type Group_Count
Experimental 627
Active Comparator 122
NA 68
Placebo Comparator 37
No Intervention 36
Other 27
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 268
Parallel Assignment 203
NA 43
Sequential Assignment 18
Factorial Assignment 4
Crossover Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 430
Diagnostic 39
Prevention 26
Supportive Care 18
Other 9
NA 9
Basic Science 3
Device Feasibility 2
Health Services Research 2
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 49
China 7
Denmark 6
NA 6
France 4
Italy 4
Spain 4
Canada 3
United Kingdom 3
Belgium 2
Egypt 2
United States|Canada 2
United States|Japan 2
Austria|Belgium|France|Germany|Greece|Italy|Netherlands|Poland|Romania 1
Austria|Czechia|France|Germany|Italy|Netherlands|Spain|Sweden|United Kingdom 1
India 1
Israel 1
Netherlands 1
Poland 1
Switzerland 1
United States|Austria|Canada|Germany|Netherlands 1
United States|Canada|Netherlands 1
United States|Netherlands|United Kingdom 1

Sites per Study

Site_count Study_Count
1 80
2 6
3 4
4 5
12 2
13 1
17 1
19 1
20 1
22 1
24 1
118 1

Enrollment Metrics

Measure Observational
Min 3.00
1st Qu 66.75
Median 198.50
Mean 25908.17
3rd Qu 665.75
Max 2323608.00

Observation Model

observational_model Study_Count
Cohort 59
Case-Control 14
Case-Only 14
Other 5
NA 4
Case Control 3
Ecologic or Community 2
Case-Crossover 1
Case Control, Natural History 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 76
Retrospective 17
Cross-Sectional 9
Longitudinal, Retrospective 1
NA 1

Registries

Studies by Country

Country Study_Count
United States 5
Austria 1
Israel 1
Netherlands 1
United Kingdom 1
United States|Australia|New Zealand|United Kingdom 1

Sites per Study

Site_count Study_Count
1 5
2 1
6 1
11 1
13 1
18 1

Enrollment Metrics

Measure Registries
Min 35.0
1st Qu 150.0
Median 750.0
Mean 3378.5
3rd Qu 3275.0
Max 20000.0

Registry Model

observational_model Study_Count
Cohort 7
Case-Crossover 1
Case-Only 1
Other 1

Time Perspective

time_perspective Study_Count
Prospective 8
Cross-Sectional 1
Other 1

Follow-up

target_duration Study_Count
1 Year 2
2 Years 2
1 Month 1
10 Years 1
12 Weeks 1
24 Months 1
3 Months 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04256616 Immunogenic Cell Death as a Novel Mechanism of Mitomycin C Activity in Bladder Cancer https://ClinicalTrials.gov/show/NCT04256616 Recruiting Istituto Clinico Humanitas 2020-09-01
NCT03327883 Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer https://ClinicalTrials.gov/show/NCT03327883 Completed National Institutes of Health Clinical Center (CC) 2018-10-16
NCT03325231 Factors Influencing Patient Choice of Bladder Reconstruction Following Radical Cystectomy https://ClinicalTrials.gov/show/NCT03325231 Recruiting Swansea University 2021-09-30
NCT03193541 A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer https://ClinicalTrials.gov/show/NCT03193541 Recruiting Cedars-Sinai Medical Center 2021-12-30
NCT03193528 A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer https://ClinicalTrials.gov/show/NCT03193528 Recruiting Cedars-Sinai Medical Center 2021-12-30
NCT03193515 A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer https://ClinicalTrials.gov/show/NCT03193515 Recruiting Cedars-Sinai Medical Center 2021-12-30
NCT03156244 Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients https://ClinicalTrials.gov/show/NCT03156244 Completed UNC Lineberger Comprehensive Cancer Center 2018-05-05
NCT03133286 Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) https://ClinicalTrials.gov/show/NCT03133286 Recruiting DxTerity Diagnostics 2019-09-06
NCT03125460 Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer https://ClinicalTrials.gov/show/NCT03125460 Completed Cepheid 2019-02-28
NCT03122964 Multi Institutional Study in Patient Presenting With Hematuria https://ClinicalTrials.gov/show/NCT03122964 Active, not recruiting MDx Health 2020-02-28
NCT03066310 Urine-DNA Biomarkers in Detecting Bladder Cancer https://ClinicalTrials.gov/show/NCT03066310 Enrolling by invitation Xiangya Hospital of Central South University 2019-10-31
NCT03065725 Early Versus Late FDG-PET/CT in Bladder Cancer https://ClinicalTrials.gov/show/NCT03065725 Active, not recruiting Aarhus University Hospital 2019-08-13
NCT03063125 Hypogonadism in Bladder Cancer https://ClinicalTrials.gov/show/NCT03063125 Active, not recruiting University of Kansas Medical Center 2020-05-30
NCT03029663 Complications of Transurethral Resection of the Bladder Tumour https://ClinicalTrials.gov/show/NCT03029663 Completed Medical University of Warsaw 2017-09-30
NCT03013894 Confocal Laser Endomicroscopy in the Lower Urinary Tract https://ClinicalTrials.gov/show/NCT03013894 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2017-10-31
NCT02957370 Molecular Biosensors for Detection of Bladder Cancer https://ClinicalTrials.gov/show/NCT02957370 Recruiting University of California, Irvine 2019-06-30
NCT02857634 Confocal Microscopy Dual Band in the Management of Bladder Cancer https://ClinicalTrials.gov/show/NCT02857634 Completed Lille Catholic University 2016-09-30
NCT02781428 To Detect the Sensitivity of the UroMark Assay https://ClinicalTrials.gov/show/NCT02781428 Active, not recruiting University College, London 2020-09-30
NCT02756637 Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710 https://ClinicalTrials.gov/show/NCT02756637 Completed Abramson Cancer Center of the University of Pennsylvania 2016-10-31
NCT02745301 Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder https://ClinicalTrials.gov/show/NCT02745301 Completed Vanderbilt University Medical Center 2018-01-31
NCT02735512 MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer https://ClinicalTrials.gov/show/NCT02735512 Recruiting University of Southern California 2020-03-01
NCT02695121 Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment https://ClinicalTrials.gov/show/NCT02695121 Recruiting AstraZeneca 2025-02-28
NCT01935466 Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy “PROBE” https://ClinicalTrials.gov/show/NCT01935466 Recruiting Postgraduate Institute of Medical Education and Research 2020-12-31
NCT00341861 Interdisciplinary Case-Control Study of Bladder Cancer in Spain https://ClinicalTrials.gov/show/NCT00341861 Completed National Institutes of Health Clinical Center (CC) NA
NCT00745355 Quality of Life in Patients With Bladder Cancer https://ClinicalTrials.gov/show/NCT00745355 Active, not recruiting Memorial Sloan Kettering Cancer Center 2020-08-31
NCT02538809 Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals https://ClinicalTrials.gov/show/NCT02538809 Recruiting Swiss Paraplegic Centre Nottwil 2021-12-31
NCT02427321 Cystoscopic Imaging Collection and Enhancement pROject https://ClinicalTrials.gov/show/NCT02427321 Completed Biosignatures Limited 2015-10-31
NCT02400944 Determinants of Bladder Cancer Recurrence Study (The DETER Study) https://ClinicalTrials.gov/show/NCT02400944 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-03-31
NCT02381912 Sexual Function in Patients Suspected of Non-muscle Invasive Bladder Cancer https://ClinicalTrials.gov/show/NCT02381912 Completed Herlev Hospital 2016-01-31
NCT02345473 Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy https://ClinicalTrials.gov/show/NCT02345473 Completed Azienda Ospedaliero-Universitaria Consorziale 2014-10-31
NCT02328417 Enhanced Recovery After Radical Cystectomy Study https://ClinicalTrials.gov/show/NCT02328417 Completed Hospital Universitario Fundación Alcorcón 2017-02-28
NCT02217891 IFACT: Incidental Findings in Advanced Cancer Therapy https://ClinicalTrials.gov/show/NCT02217891 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-08-31
NCT02203136 Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging https://ClinicalTrials.gov/show/NCT02203136 Completed M.D. Anderson Cancer Center 2019-05-16
NCT02186925 A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. https://ClinicalTrials.gov/show/NCT02186925 Recruiting Meir Medical Center 2019-08-31
NCT02113501 Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study https://ClinicalTrials.gov/show/NCT02113501 Completed Hospital Universitari Vall d’Hebron Research Institute 2013-12-31
NCT02039310 Prediction of Impaired Survival in Elderly Bladder Cancer Patients Opting for Radical Cystectomy https://ClinicalTrials.gov/show/NCT02039310 Completed University of Michigan 2015-12-31
NCT03433924 An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients. https://ClinicalTrials.gov/show/NCT03433924 Recruiting AstraZeneca 2023-05-29
NCT01810445 Endoscopic Subsurface Optical Imaging for Cancer Detection https://ClinicalTrials.gov/show/NCT01810445 Completed University of California, Davis 2011-08-31
NCT01776138 Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer https://ClinicalTrials.gov/show/NCT01776138 Recruiting UNC Lineberger Comprehensive Cancer Center 2020-04-30
NCT01706185 Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer https://ClinicalTrials.gov/show/NCT01706185 Completed GlaxoSmithKline 2008-01-15
NCT01447199 The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) https://ClinicalTrials.gov/show/NCT01447199 Active, not recruiting M.D. Anderson Cancer Center 2020-09-30
NCT01444456 Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia https://ClinicalTrials.gov/show/NCT01444456 Completed Amgen 2013-08-31
NCT04410302 Patient-Derived Xenografts to Reduce Cancer Health Disparities https://ClinicalTrials.gov/show/NCT04410302 Recruiting University of California, Davis 2023-06-30
NCT04406168 Assessment of Urinary Diversions Outcomes Post Radical Cystectomy in Asyut University Urology Hospital https://ClinicalTrials.gov/show/NCT04406168 Recruiting Assiut University 2022-05-01
NCT04385316 Clinical Study of Gastric Cancer, Colorectal Cancer and Bladder Cancer Based on Liquid Biopsy https://ClinicalTrials.gov/show/NCT04385316 Recruiting The First Affiliated Hospital with Nanjing Medical University 2020-12-31
NCT04334226 The Impact of Preoperative Urostomy Education on Patients and Families https://ClinicalTrials.gov/show/NCT04334226 Enrolling by invitation University of Kansas Medical Center 2020-07-30
NCT04314245 Diagnostic Evaluation of Urine DNA Methylation/Somatic Mutation Profiling for the Detection of Urothelial Carcinoma https://ClinicalTrials.gov/show/NCT04314245 Recruiting AnchorDx Medical Co., Ltd. 2020-08-31
NCT04310813 Microscopic-spectroscopic Examination for Urothelial Tissue Characterization https://ClinicalTrials.gov/show/NCT04310813 Completed Careggi Hospital 2019-12-01
NCT04282876 Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer https://ClinicalTrials.gov/show/NCT04282876 Recruiting Aarhus University Hospital 2022-02-01
NCT04256122 Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors (“Non-responders”) and Non-recurrent Tumors (“Responders”) After Intravesical Treatment With Chemotherapy or Immunotherapy https://ClinicalTrials.gov/show/NCT04256122 Recruiting Istituto Clinico Humanitas 2020-10-31
NCT04228198 Protocol of the Italian Radical Cystectomy Registry https://ClinicalTrials.gov/show/NCT04228198 Recruiting University of Roma La Sapienza 2020-01-01
NCT04162704 EpiCheck and Short-term Intensive Chemoresection in NMIBC https://ClinicalTrials.gov/show/NCT04162704 Recruiting Aarhus University Hospital 2020-10-31
NCT04155359 Clinical Evaluation of the miR Sentinel BCaâ„¢ Test to Diagnose Bladder Cancer in Hematuria Patients https://ClinicalTrials.gov/show/NCT04155359 Recruiting miR Scientific LLC 2022-12-31
NCT04144270 The Importance of Muscle Function in Patients With Disseminated Bladder Cancer https://ClinicalTrials.gov/show/NCT04144270 Recruiting Rigshospitalet, Denmark 2021-04-30
NCT04089748 Basal Tumours in Bladder Cancer, Response to chemoTherapy https://ClinicalTrials.gov/show/NCT04089748 Recruiting University Hospital, Rouen 2023-03-31
NCT04053101 Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer https://ClinicalTrials.gov/show/NCT04053101 Active, not recruiting Institut Bergonié 2018-12-31
NCT04036877 Mood Disorders Bladder Cancer https://ClinicalTrials.gov/show/NCT04036877 Recruiting University of Kansas Medical Center 2021-07-31
NCT03973671 Flemish Databank for Urothelial Cancer https://ClinicalTrials.gov/show/NCT03973671 Recruiting Universitaire Ziekenhuizen Leuven 2024-03-31
NCT03973307 UroX Biomarker Bladder Cancer Study https://ClinicalTrials.gov/show/NCT03973307 Recruiting East and North Hertfordshire NHS Trust 2020-07-01
NCT03933826 CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer https://ClinicalTrials.gov/show/NCT03933826 Recruiting University of Washington 2023-10-31
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) https://ClinicalTrials.gov/show/NCT03896958 Recruiting SpeciCare 2021-03-12
NCT03892031 Circulatory Function in Laparoscopic Radical Cystectomy for Bladder Cancer https://ClinicalTrials.gov/show/NCT03892031 Recruiting RenJi Hospital 2019-12-31
NCT03863028 Development and Validation of a Simulator-based Test in Transurethral Resection of Bladder Tumors https://ClinicalTrials.gov/show/NCT03863028 Completed Rigshospitalet, Denmark 2018-09-21
NCT03801954 Implementation of Nutrition Education Videos for Patients Undergoing Radical Cystectomy https://ClinicalTrials.gov/show/NCT03801954 Recruiting University of Kansas Medical Center 2020-12-31
NCT03789682 CD155 in Bladder Cancer https://ClinicalTrials.gov/show/NCT03789682 Recruiting Fudan University 2023-01-01
NCT03739177 Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients https://ClinicalTrials.gov/show/NCT03739177 Recruiting Animated Dynamics, Inc. 2020-06-30
NCT01264744 Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test) https://ClinicalTrials.gov/show/NCT01264744 Completed Applied Spectral Imaging Ltd. 2010-08-31
NCT01236053 Cancer in Patients With Gabapentin (GPRD) https://ClinicalTrials.gov/show/NCT01236053 Completed GlaxoSmithKline 2010-09-30
NCT01166230 Longer-term Recurrence Rates in Patients With Bladder Cancer After Hexvix (Cysview)Fluorescence Cystoscopy/TURB https://ClinicalTrials.gov/show/NCT01166230 Completed Photocure 2010-12-31
NCT01135849 B-Receptor Signaling in Cardiomyopathy https://ClinicalTrials.gov/show/NCT01135849 Completed Stanford University 2010-10-31
NCT01090388 Bladder Cancer Patient-Reported Outcomes https://ClinicalTrials.gov/show/NCT01090388 Completed Baylor College of Medicine 2011-08-31
NCT01050504 Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer https://ClinicalTrials.gov/show/NCT01050504 Recruiting University of Washington 2021-09-01
NCT01015963 Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871 https://ClinicalTrials.gov/show/NCT01015963 Completed Alliance for Clinical Trials in Oncology 2013-01-31
NCT01007058 Markers of Response to Intravesical Bladder Cancer Therapy https://ClinicalTrials.gov/show/NCT01007058 Completed M.D. Anderson Cancer Center 2016-04-30
NCT00903240 Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer https://ClinicalTrials.gov/show/NCT00903240 Completed Predictive Biosciences 2010-04-30
NCT00902590 A Genotype-Phenotype Urothelial Cancer Registry https://ClinicalTrials.gov/show/NCT00902590 Recruiting Memorial Sloan Kettering Cancer Center 2023-05-31
NCT00900276 Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants https://ClinicalTrials.gov/show/NCT00900276 Completed Wake Forest University Health Sciences 2011-04-30
NCT00872495 Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer https://ClinicalTrials.gov/show/NCT00872495 Active, not recruiting Lahey Clinic 2025-10-31
NCT00871754 Molecular Analysis Of Bladder Cancer https://ClinicalTrials.gov/show/NCT00871754 Active, not recruiting Lahey Clinic 2020-12-31
NCT00848627 Screening for Bladder Cancer https://ClinicalTrials.gov/show/NCT00848627 Completed Baylor College of Medicine 2012-01-31
NCT00848289 Genetic Susceptibility to Bladder Cancer https://ClinicalTrials.gov/show/NCT00848289 Recruiting M.D. Anderson Cancer Center 2024-08-31
NCT00829920 The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease https://ClinicalTrials.gov/show/NCT00829920 Completed University of Colorado, Denver 2012-11-30
NCT01637935 Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes https://ClinicalTrials.gov/show/NCT01637935 Completed Takeda 2014-08-31
NCT01395225 Lymph Node Processing Protocol for Radical Cystectomy and Pelvic Lymph Node Dissection in Bladder Cancer https://ClinicalTrials.gov/show/NCT01395225 Completed University of British Columbia 2013-04-30
NCT00801762 Fiber-Optic Confocal Microscopy of the Urinary Tract Histopathology https://ClinicalTrials.gov/show/NCT00801762 Completed Stanford University 2015-02-28
NCT00342875 The New England Bladder Cancer Study https://ClinicalTrials.gov/show/NCT00342875 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001823 Evaluation for NCI Surgery Branch Clinical Research Protocols https://ClinicalTrials.gov/show/NCT00001823 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03121768 A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) https://ClinicalTrials.gov/show/NCT03121768 Recruiting Mansoura University 2019-12-01
NCT03664258 A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) https://ClinicalTrials.gov/show/NCT03664258 Recruiting Cepheid 2021-06-30
NCT03499782 Precise Treatment System of Biliary Malignancies Based on Special Disease Database https://ClinicalTrials.gov/show/NCT03499782 Recruiting Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2021-08-31
NCT00776178 Follow-Up of Bladder Cancer Patients From the New England Study of Environment and Health https://ClinicalTrials.gov/show/NCT00776178 Completed National Institutes of Health Clinical Center (CC) 2020-03-31
NCT00772018 Quality of Life and Symptom Management in Patients With Bladder Cancer https://ClinicalTrials.gov/show/NCT00772018 Completed Baylor College of Medicine 2010-09-30
NCT00744744 Health-Related Quality of Life in Patients With Bladder Cancer https://ClinicalTrials.gov/show/NCT00744744 Completed Baylor College of Medicine 2011-07-31
NCT00634621 Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer https://ClinicalTrials.gov/show/NCT00634621 Completed GE Healthcare 2010-09-30
NCT00612326 Feasibility Evaluation of Magnetic Resonance Imaging and Positron Emission Tomography for Bladder Cancer Diagnosis and Staging https://ClinicalTrials.gov/show/NCT00612326 Completed Memorial Sloan Kettering Cancer Center 2008-03-31
NCT00582387 Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer https://ClinicalTrials.gov/show/NCT00582387 Completed Memorial Sloan Kettering Cancer Center 2013-07-31
NCT00469066 Cone Beam CT Scanning in Lung and Bladder Cancer. https://ClinicalTrials.gov/show/NCT00469066 Completed AHS Cancer Control Alberta 2009-08-31
NCT00339443 Calibration of Urine pH Strips for NCI Case-Control Studies on Bladder Cancer and Comparison of DNA Yields From Buccal Cells Collected Through Two Different Methods https://ClinicalTrials.gov/show/NCT00339443 Completed National Institutes of Health Clinical Center (CC) NA
NCT00318266 NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers. https://ClinicalTrials.gov/show/NCT00318266 Completed Lawson Health Research Institute 2008-05-31
NCT00315653 Survivin Urine mRNA Assay Risk of Bladder Cancer Study https://ClinicalTrials.gov/show/NCT00315653 Completed Fujirebio Diagnostics, Inc. NA
NCT00310115 Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy https://ClinicalTrials.gov/show/NCT00310115 Completed M.D. Anderson Cancer Center 2016-08-31
NCT00213655 URO-BCG-4 : Bladder Tumors Immunotherapy https://ClinicalTrials.gov/show/NCT00213655 Completed University Hospital, Rouen 2013-05-31
NCT00095589 Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer https://ClinicalTrials.gov/show/NCT00095589 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2009-06-30
NCT00011518 Bladder Cancer Case Control Study of Arsenic in Water https://ClinicalTrials.gov/show/NCT00011518 Completed National Institute of Environmental Health Sciences (NIEHS) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03301493 Genomic Testing and Resulting Medical Decisions https://ClinicalTrials.gov/show/NCT03301493 Recruiting Arbeitsgemeinschaft medikamentoese Tumortherapie 2019-12-31
NCT03193970 Measuring Surgical Recovery After Radical Cystectomy https://ClinicalTrials.gov/show/NCT03193970 Recruiting M.D. Anderson Cancer Center 2034-12-31
NCT02676180 Detecting Bladder Cancer Using the UroMark Test. https://ClinicalTrials.gov/show/NCT02676180 Completed University College, London 2017-12-31
NCT02660645 Blue Light Cystoscopy With Cysview® Registry https://ClinicalTrials.gov/show/NCT02660645 Recruiting Photocure 2020-12-31
NCT02852252 Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry https://ClinicalTrials.gov/show/NCT02852252 Recruiting University of Pennsylvania 2020-12-31
NCT02298998 Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study https://ClinicalTrials.gov/show/NCT02298998 Recruiting The University of Texas Health Science Center at San Antonio 2022-05-31
NCT01955408 Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment https://ClinicalTrials.gov/show/NCT01955408 Completed Meir Medical Center 2016-12-31
NCT04075305 The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study https://ClinicalTrials.gov/show/NCT04075305 Recruiting UMC Utrecht 2024-02-01
NCT03413982 Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers https://ClinicalTrials.gov/show/NCT03413982 Recruiting University of Kansas Medical Center 2030-01-01
NCT03091764 Evaluation of a Patient-Reported Symptom Index for NMIBC https://ClinicalTrials.gov/show/NCT03091764 Recruiting University of Sydney 2020-06-30